CONTINGENT CONSIDERATION LIABILITY (Tables)

12 Months Ended

Dec. 31, 2016

Notes to Financial Statements

Therapeutics Contingent Consideration

One-Year Anniversary Date Revenue		Probability			Revenue-Based Payment		Probability-Weighted Amounts
$	3,200,000		0.00	%	$	800,000	$	–
$	2,000,000		0.50	%	$	200,000		1,000
$	1,599,999		99.50	%	$	–		–
Fair Value of Expected Earn-out Payment								1,000
Discount Rate								25	%
Payments							$	0
Present Value Factor at 20% Discount Rate for 12 Months								0.9457
Present Value of Contingent Consideration							$	946

Performance-Based Cash Consideration

Year 1 Revenue	$	16,666,666
Less:		12,000,000
	$	4,666,666
		0.44742864
Performance-Based Cash Payment	$	2,088,000

Black Oak Contingent Consideration

			One-Year
			Anniversary			Value of							Probability-Weighted
			Date of the			Common		Performance-					Amounts
Year 1			Merger 30-			Stock to		Based Cash					Earn-Out		Performance-
Revenue			Day VWAP			Issue		Payment		Probability			Shares		Based Cash		Total
				20	%	$	15,788,827	$	2,088,000		4.0	%	$	631,553	$	83,520	$	715,073
			$	0.2108
Upside	20	%		70	%	$	13,824,526	$	2,088,000		14.0	%	$	1,935,434	$	292,320	$	2,227,754

$	16,667,000			$	0.3108
					10	%	$	12,816,555	$	2,088,000	2.0	%	$	256,331		$	41,760		$	298,091
				$	0.4108
					20	%	$	11,867,575	$	747,500	15.0	%	$	1,780,136		$	112,125		$	1,892,261
				$	0.2108
Base		75	%		70	%	$	11,164,938	$	747,500	52.5	%	$	5,861,592		$	392,438		$	6,254,030
$	13,670,835			$	0.3108
					10	%	$	10,804,383	$	747,500	7.5	%	$	810,329		$	56,063		$	866,391
				$	0.4108
					20	%	$	7,251,428	$	–	1.0	%	$	72,514		$	–		$	72,514
				$	0.2108
Downside		5	%		70	%	$	8,034,038	$	–	3.5	%	$	281,191		$	–		$	281,191
$	10,674,670			$	0.3108
					10	%	$	8,435,630	$	–	0.5	%	$	42,178		$	–		$	42,178
				$	0.4108
				Fair Value of Expected Earn-Out Payment									$	11,671,259		$	978,225		$	12,649,484
				Price Per Common Share									$	0.2620		$	0.2620
				Discount Rate										20	%		20	%
				Periods (nper)										0.250			0.250
				Payments									$	–		$	–
				Present Value Factor at 20% Discount Rate for 12 Months										0.9554			0.9554
				Present Value of Contingent Consideration									$	11,151,221		$	934,638
				Present Value of Contingent Consideration															$	12,085,859

Summarizes adjustments Contingent Consideration

	Preliminary April 1, 2016		Adjust- ments June 30, 2016			June 30, 2016		Adjust- ments September 30, 2016				September 30, 2016		Adjust- ments December 31, 2016				Final as of December 31, 2016
Holdback Consideration Stock	$	11,324,969	$	(514,339	)	$	10,810,630	$	217,895			$	11,028,525	$	122,695			$	11,151,220
Performance-Based Cash		1,429,583		66,669			1,496,252		130,963				1,627,215		(692,577	)			934,638
Adjustment to Goodwill		–		447,670	(1)		–		(348,858	)	(1)		–		(98,812	)	(2)		–
Change in Fair Value of Contingent Consideration		–		–			–		–				–		98,812				–
Total Contingent Consideration	$	12,754,553	$	–		$	12,306,882	$	–			$	12,655,740	$	(569,882	)		$	12,085,858